written on 10.06.2019

Library > White Papers > Fasken

Contributed by Fasken


Serge Lapointe PhD, Partner and Patent Agent at Fasken Law Firm examines the current state of patents in the North American cannabis industry. Cannabis is licensed for medical purposes in Canada and, as of October 17, 2018, adult Canadians can legally consume cannabis for recreational purposes.

The legalization of cannabis raises many questions, in terms of public health, regulation, cultivation, supply, distribution, etc. In this piece, Lapointe discusses cannabis from the perspective of patents, a topic that is probably not the first that comes to mind.

This white paper briefly reviews the current financial situation of the Canadian cannabis industry, examines recent patent filing activities, and looks at current and concrete examples of patents in various categories.

Related White Papers

Lessons Learned from COVID-19
Intelligent Biopharma: Forging the links across the value chain
Reimagining Global Health through Artificial Intelligence: The Roadmap to AI Maturity
We use cookies to ensure that we give you the best experience on our site. For more info click here